Beta carotene - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for beta carotene and what is the scope of freedom to operate?
Beta carotene
is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for beta carotene.
Summary for beta carotene
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 111 |
Clinical Trials: | 34 |
Patent Applications: | 67 |
DailyMed Link: | beta carotene at DailyMed |
Recent Clinical Trials for beta carotene
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Duta Wacana Christian University | Phase 4 |
Dexa Medica Group | Phase 4 |
Aga Khan University Hospital, Pakistan | N/A |
Medical Subject Heading (MeSH) Categories for beta carotene
US Patents and Regulatory Information for beta carotene
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | SOLATENE | beta carotene | CAPSULE;ORAL | 017589-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |